NeoProteomics specializes in structural mass spectrometry and hydroxyl radical protein footprinting, positioning itself as a leader in these advanced techniques since 2006. The company provides essential contract research services to pharmaceutical and biotech firms, helping them obtain critical structural information for protein-based drugs and pharmaceuticals. Their expertise in protein footprinting is particularly noteworthy, as it is one of the few companies utilizing this method to facilitate drug discovery and medicinal chemistry, thereby enhancing the development of new therapeutic solutions.

The focus on structural biology allows NeoProteomics to address complex challenges in research and development. They offer proof of concept experiments, demonstrating their commitment to providing tailored solutions for various structural biology problems. By leveraging their innovative technologies, NeoProteomics aims to accelerate research processes while maintaining affordability and minimizing risk for their clients in the pharmaceutical and biotech sectors.

United States

NeoProteomics, Inc. offers covalent labeling (CL) and mass spectrometry (MS) services to industry to characterize therapeutic proteins.

NeoProteomics

Company Details